nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—TEC—rheumatoid arthritis	0.395	0.791	CbGaD
Dasatinib—BLK—rheumatoid arthritis	0.104	0.209	CbGaD
Dasatinib—ABCG2—Leflunomide—rheumatoid arthritis	0.0216	0.124	CbGbCtD
Dasatinib—CYP1B1—Dexamethasone—rheumatoid arthritis	0.014	0.0802	CbGbCtD
Dasatinib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0134	0.0764	CbGbCtD
Dasatinib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0107	0.0613	CbGbCtD
Dasatinib—ABCG2—Cyclosporine—rheumatoid arthritis	0.0101	0.0579	CbGbCtD
Dasatinib—CYP1A2—Leflunomide—rheumatoid arthritis	0.00891	0.051	CbGbCtD
Dasatinib—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0074	0.0423	CbGbCtD
Dasatinib—ABCG2—Dexamethasone—rheumatoid arthritis	0.00666	0.0381	CbGbCtD
Dasatinib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00635	0.0363	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—rheumatoid arthritis	0.00615	0.0352	CbGbCtD
Dasatinib—SRMS—knee—rheumatoid arthritis	0.00597	0.101	CbGeAlD
Dasatinib—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.00594	0.034	CbGbCtD
Dasatinib—CYP3A5—Cyclosporine—rheumatoid arthritis	0.00561	0.0321	CbGbCtD
Dasatinib—ABCG2—Methotrexate—rheumatoid arthritis	0.00535	0.0306	CbGbCtD
Dasatinib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00516	0.0295	CbGbCtD
Dasatinib—ABCB1—Betamethasone—rheumatoid arthritis	0.00413	0.0236	CbGbCtD
Dasatinib—ABCB1—Prednisolone—rheumatoid arthritis	0.00408	0.0233	CbGbCtD
Dasatinib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00386	0.0221	CbGbCtD
Dasatinib—ABCB1—Prednisone—rheumatoid arthritis	0.00385	0.022	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00381	0.0218	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—rheumatoid arthritis	0.00369	0.0211	CbGbCtD
Dasatinib—ABCB1—Cyclosporine—rheumatoid arthritis	0.00365	0.0209	CbGbCtD
Dasatinib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00288	0.0165	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00247	0.0142	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00244	0.014	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—rheumatoid arthritis	0.0024	0.0137	CbGbCtD
Dasatinib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00231	0.0132	CbGbCtD
Dasatinib—CYP3A4—Prednisone—rheumatoid arthritis	0.00231	0.0132	CbGbCtD
Dasatinib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00219	0.0125	CbGbCtD
Dasatinib—ABCB1—Methotrexate—rheumatoid arthritis	0.00193	0.011	CbGbCtD
Dasatinib—RIPK2—synovial membrane of synovial joint—rheumatoid arthritis	0.00189	0.0321	CbGeAlD
Dasatinib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00144	0.00824	CbGbCtD
Dasatinib—WEE2—lymphoid tissue—rheumatoid arthritis	0.00109	0.0186	CbGeAlD
Dasatinib—ERBB3—exocrine gland—rheumatoid arthritis	0.00087	0.0148	CbGeAlD
Dasatinib—TEC—lymphoid tissue—rheumatoid arthritis	0.00083	0.0141	CbGeAlD
Dasatinib—SIK2—connective tissue—rheumatoid arthritis	0.000786	0.0134	CbGeAlD
Dasatinib—TEC—tendon—rheumatoid arthritis	0.00078	0.0133	CbGeAlD
Dasatinib—PTK6—saliva-secreting gland—rheumatoid arthritis	0.000763	0.013	CbGeAlD
Dasatinib—SRMS—connective tissue—rheumatoid arthritis	0.000716	0.0122	CbGeAlD
Dasatinib—STAT5B—connective tissue—rheumatoid arthritis	0.000663	0.0113	CbGeAlD
Dasatinib—EPHB1—tendon—rheumatoid arthritis	0.000612	0.0104	CbGeAlD
Dasatinib—FRK—lymphoid tissue—rheumatoid arthritis	0.00056	0.00952	CbGeAlD
Dasatinib—TESK1—parotid gland—rheumatoid arthritis	0.000557	0.00946	CbGeAlD
Dasatinib—BLK—lymphoid tissue—rheumatoid arthritis	0.000541	0.00919	CbGeAlD
Dasatinib—LYN—connective tissue—rheumatoid arthritis	0.000539	0.00917	CbGeAlD
Dasatinib—EPHB2—lymphoid tissue—rheumatoid arthritis	0.000535	0.00908	CbGeAlD
Dasatinib—TESK1—saliva-secreting gland—rheumatoid arthritis	0.000533	0.00906	CbGeAlD
Dasatinib—KIT—exocrine gland—rheumatoid arthritis	0.000532	0.00904	CbGeAlD
Dasatinib—BTK—connective tissue—rheumatoid arthritis	0.000529	0.00898	CbGeAlD
Dasatinib—EPHB2—digestive system—rheumatoid arthritis	0.000528	0.00897	CbGeAlD
Dasatinib—EPHB3—saliva-secreting gland—rheumatoid arthritis	0.000525	0.00891	CbGeAlD
Dasatinib—TXK—lymphoid tissue—rheumatoid arthritis	0.000518	0.0088	CbGeAlD
Dasatinib—SRMS—digestive system—rheumatoid arthritis	0.000517	0.00878	CbGeAlD
Dasatinib—CSK—parotid gland—rheumatoid arthritis	0.00051	0.00866	CbGeAlD
Dasatinib—PTK6—digestive system—rheumatoid arthritis	0.000506	0.0086	CbGeAlD
Dasatinib—TESK1—connective tissue—rheumatoid arthritis	0.00049	0.00832	CbGeAlD
Dasatinib—CSK—saliva-secreting gland—rheumatoid arthritis	0.000488	0.0083	CbGeAlD
Dasatinib—STAT5B—lymphoid tissue—rheumatoid arthritis	0.000485	0.00824	CbGeAlD
Dasatinib—STAT5B—digestive system—rheumatoid arthritis	0.000479	0.00813	CbGeAlD
Dasatinib—RIPK2—parotid gland—rheumatoid arthritis	0.000473	0.00804	CbGeAlD
Dasatinib—SIK1—parotid gland—rheumatoid arthritis	0.000462	0.00785	CbGeAlD
Dasatinib—RIPK2—saliva-secreting gland—rheumatoid arthritis	0.000453	0.0077	CbGeAlD
Dasatinib—CSK—connective tissue—rheumatoid arthritis	0.000449	0.00762	CbGeAlD
Dasatinib—SIK1—saliva-secreting gland—rheumatoid arthritis	0.000443	0.00752	CbGeAlD
Dasatinib—ERBB3—saliva-secreting gland—rheumatoid arthritis	0.000434	0.00737	CbGeAlD
Dasatinib—RIPK2—connective tissue—rheumatoid arthritis	0.000416	0.00708	CbGeAlD
Dasatinib—SIK3—tendon—rheumatoid arthritis	0.00041	0.00696	CbGeAlD
Dasatinib—SIK1—connective tissue—rheumatoid arthritis	0.000407	0.00691	CbGeAlD
Dasatinib—FMO3—parotid gland—rheumatoid arthritis	0.000406	0.00689	CbGeAlD
Dasatinib—ZAK—lymphoid tissue—rheumatoid arthritis	0.000405	0.00688	CbGeAlD
Dasatinib—ZAK—digestive system—rheumatoid arthritis	0.0004	0.0068	CbGeAlD
Dasatinib—EPHB4—parotid gland—rheumatoid arthritis	0.0004	0.00679	CbGeAlD
Dasatinib—ERBB3—connective tissue—rheumatoid arthritis	0.000399	0.00677	CbGeAlD
Dasatinib—MAP3K2—connective tissue—rheumatoid arthritis	0.000395	0.00671	CbGeAlD
Dasatinib—LYN—lymphoid tissue—rheumatoid arthritis	0.000394	0.0067	CbGeAlD
Dasatinib—EPHA2—parotid gland—rheumatoid arthritis	0.000392	0.00667	CbGeAlD
Dasatinib—EPHA5—digestive system—rheumatoid arthritis	0.000392	0.00665	CbGeAlD
Dasatinib—BTK—lymphoid tissue—rheumatoid arthritis	0.000387	0.00657	CbGeAlD
Dasatinib—EPHB4—saliva-secreting gland—rheumatoid arthritis	0.000383	0.00651	CbGeAlD
Dasatinib—MAP4K5—parotid gland—rheumatoid arthritis	0.000383	0.0065	CbGeAlD
Dasatinib—MAP3K3—parotid gland—rheumatoid arthritis	0.000383	0.0065	CbGeAlD
Dasatinib—ZAK—tendon—rheumatoid arthritis	0.000381	0.00647	CbGeAlD
Dasatinib—EPHA2—saliva-secreting gland—rheumatoid arthritis	0.000376	0.00638	CbGeAlD
Dasatinib—MAPK14—connective tissue—rheumatoid arthritis	0.000371	0.00631	CbGeAlD
Dasatinib—MAP4K5—saliva-secreting gland—rheumatoid arthritis	0.000367	0.00623	CbGeAlD
Dasatinib—MAP3K3—saliva-secreting gland—rheumatoid arthritis	0.000367	0.00623	CbGeAlD
Dasatinib—EPHB6—parotid gland—rheumatoid arthritis	0.000366	0.00621	CbGeAlD
Dasatinib—BTK—tendon—rheumatoid arthritis	0.000363	0.00617	CbGeAlD
Dasatinib—YES1—parotid gland—rheumatoid arthritis	0.000353	0.00601	CbGeAlD
Dasatinib—EPHB4—connective tissue—rheumatoid arthritis	0.000352	0.00598	CbGeAlD
Dasatinib—EPHB6—saliva-secreting gland—rheumatoid arthritis	0.00035	0.00595	CbGeAlD
Dasatinib—JAK2—connective tissue—rheumatoid arthritis	0.000349	0.00594	CbGeAlD
Dasatinib—EPHB3—digestive system—rheumatoid arthritis	0.000348	0.00592	CbGeAlD
Dasatinib—FYN—connective tissue—rheumatoid arthritis	0.000345	0.00586	CbGeAlD
Dasatinib—LIMK2—lymphoid tissue—rheumatoid arthritis	0.000341	0.00579	CbGeAlD
Dasatinib—YES1—saliva-secreting gland—rheumatoid arthritis	0.000339	0.00575	CbGeAlD
Dasatinib—TESK1—tendon—rheumatoid arthritis	0.000337	0.00572	CbGeAlD
Dasatinib—STK36—tendon—rheumatoid arthritis	0.000331	0.00563	CbGeAlD
Dasatinib—CSK—lymphoid tissue—rheumatoid arthritis	0.000328	0.00557	CbGeAlD
Dasatinib—CSK—digestive system—rheumatoid arthritis	0.000324	0.00551	CbGeAlD
Dasatinib—HCK—lymphoid tissue—rheumatoid arthritis	0.000324	0.0055	CbGeAlD
Dasatinib—HCK—digestive system—rheumatoid arthritis	0.00032	0.00544	CbGeAlD
Dasatinib—MAP2K5—parotid gland—rheumatoid arthritis	0.000313	0.00531	CbGeAlD
Dasatinib—YES1—connective tissue—rheumatoid arthritis	0.000311	0.00528	CbGeAlD
Dasatinib—STK35—tendon—rheumatoid arthritis	0.00031	0.00528	CbGeAlD
Dasatinib—CSK—tendon—rheumatoid arthritis	0.000308	0.00524	CbGeAlD
Dasatinib—PDGFRA—connective tissue—rheumatoid arthritis	0.000305	0.00518	CbGeAlD
Dasatinib—HCK—tendon—rheumatoid arthritis	0.000304	0.00517	CbGeAlD
Dasatinib—ABL2—tendon—rheumatoid arthritis	0.000303	0.00514	CbGeAlD
Dasatinib—RIPK2—digestive system—rheumatoid arthritis	0.000301	0.00511	CbGeAlD
Dasatinib—MAP2K5—saliva-secreting gland—rheumatoid arthritis	0.0003	0.00509	CbGeAlD
Dasatinib—SRC—connective tissue—rheumatoid arthritis	0.000299	0.00508	CbGeAlD
Dasatinib—SIK1—lymphoid tissue—rheumatoid arthritis	0.000297	0.00505	CbGeAlD
Dasatinib—ERBB3—lymphoid tissue—rheumatoid arthritis	0.000291	0.00495	CbGeAlD
Dasatinib—MAP3K2—lymphoid tissue—rheumatoid arthritis	0.000289	0.00491	CbGeAlD
Dasatinib—ERBB3—digestive system—rheumatoid arthritis	0.000288	0.00489	CbGeAlD
Dasatinib—RIPK2—tendon—rheumatoid arthritis	0.000286	0.00486	CbGeAlD
Dasatinib—SIK1—tendon—rheumatoid arthritis	0.00028	0.00475	CbGeAlD
Dasatinib—KIT—parotid gland—rheumatoid arthritis	0.000277	0.00471	CbGeAlD
Dasatinib—EPHA4—tendon—rheumatoid arthritis	0.000277	0.0047	CbGeAlD
Dasatinib—MAPK14—lymphoid tissue—rheumatoid arthritis	0.000271	0.00461	CbGeAlD
Dasatinib—PDGFRB—parotid gland—rheumatoid arthritis	0.000271	0.0046	CbGeAlD
Dasatinib—FGR—lymphoid tissue—rheumatoid arthritis	0.00027	0.00459	CbGeAlD
Dasatinib—CSF1R—connective tissue—rheumatoid arthritis	0.000269	0.00456	CbGeAlD
Dasatinib—MAPK14—digestive system—rheumatoid arthritis	0.000268	0.00456	CbGeAlD
Dasatinib—FGR—digestive system—rheumatoid arthritis	0.000267	0.00454	CbGeAlD
Dasatinib—KIT—saliva-secreting gland—rheumatoid arthritis	0.000265	0.00451	CbGeAlD
Dasatinib—PDGFRB—saliva-secreting gland—rheumatoid arthritis	0.000259	0.00441	CbGeAlD
Dasatinib—JAK2—lymphoid tissue—rheumatoid arthritis	0.000256	0.00434	CbGeAlD
Dasatinib—MAPK14—tendon—rheumatoid arthritis	0.000255	0.00434	CbGeAlD
Dasatinib—EPHB4—digestive system—rheumatoid arthritis	0.000254	0.00432	CbGeAlD
Dasatinib—FGR—tendon—rheumatoid arthritis	0.000254	0.00432	CbGeAlD
Dasatinib—EPHA2—lymphoid tissue—rheumatoid arthritis	0.000252	0.00429	CbGeAlD
Dasatinib—JAK2—digestive system—rheumatoid arthritis	0.000252	0.00429	CbGeAlD
Dasatinib—FYN—lymphoid tissue—rheumatoid arthritis	0.000252	0.00428	CbGeAlD
Dasatinib—EPHA2—digestive system—rheumatoid arthritis	0.000249	0.00424	CbGeAlD
Dasatinib—FYN—digestive system—rheumatoid arthritis	0.000249	0.00423	CbGeAlD
Dasatinib—MAP4K5—lymphoid tissue—rheumatoid arthritis	0.000246	0.00418	CbGeAlD
Dasatinib—KIT—connective tissue—rheumatoid arthritis	0.000244	0.00414	CbGeAlD
Dasatinib—EPHB4—tendon—rheumatoid arthritis	0.000242	0.00411	CbGeAlD
Dasatinib—ABL1—parotid gland—rheumatoid arthritis	0.000241	0.0041	CbGeAlD
Dasatinib—JAK2—tendon—rheumatoid arthritis	0.00024	0.00408	CbGeAlD
Dasatinib—PDGFRB—connective tissue—rheumatoid arthritis	0.000238	0.00405	CbGeAlD
Dasatinib—EPHA2—tendon—rheumatoid arthritis	0.000237	0.00403	CbGeAlD
Dasatinib—FYN—tendon—rheumatoid arthritis	0.000237	0.00403	CbGeAlD
Dasatinib—MAP3K3—tendon—rheumatoid arthritis	0.000231	0.00393	CbGeAlD
Dasatinib—MAP4K5—tendon—rheumatoid arthritis	0.000231	0.00393	CbGeAlD
Dasatinib—ABL1—saliva-secreting gland—rheumatoid arthritis	0.000231	0.00393	CbGeAlD
Dasatinib—YES1—lymphoid tissue—rheumatoid arthritis	0.000227	0.00386	CbGeAlD
Dasatinib—YES1—digestive system—rheumatoid arthritis	0.000225	0.00382	CbGeAlD
Dasatinib—PDGFRA—lymphoid tissue—rheumatoid arthritis	0.000223	0.00379	CbGeAlD
Dasatinib—EPHB6—tendon—rheumatoid arthritis	0.000221	0.00376	CbGeAlD
Dasatinib—PDGFRA—digestive system—rheumatoid arthritis	0.00022	0.00374	CbGeAlD
Dasatinib—SRC—lymphoid tissue—rheumatoid arthritis	0.000219	0.00372	CbGeAlD
Dasatinib—SRC—digestive system—rheumatoid arthritis	0.000216	0.00367	CbGeAlD
Dasatinib—YES1—tendon—rheumatoid arthritis	0.000214	0.00363	CbGeAlD
Dasatinib—ABL1—connective tissue—rheumatoid arthritis	0.000212	0.00361	CbGeAlD
Dasatinib—PDGFRA—tendon—rheumatoid arthritis	0.00021	0.00356	CbGeAlD
Dasatinib—CSF1R—lymphoid tissue—rheumatoid arthritis	0.000196	0.00334	CbGeAlD
Dasatinib—CSF1R—digestive system—rheumatoid arthritis	0.000194	0.0033	CbGeAlD
Dasatinib—MAP2K5—tendon—rheumatoid arthritis	0.000189	0.00321	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—rheumatoid arthritis	0.000187	0.0864	CbGdCrCtD
Dasatinib—CSF1R—tendon—rheumatoid arthritis	0.000185	0.00314	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—rheumatoid arthritis	0.000184	0.085	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Betamethasone—rheumatoid arthritis	0.000184	0.085	CbGdCrCtD
Dasatinib—CYP1B1—connective tissue—rheumatoid arthritis	0.00018	0.00306	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—rheumatoid arthritis	0.00018	0.0831	CbGdCrCtD
Dasatinib—KIT—lymphoid tissue—rheumatoid arthritis	0.000178	0.00303	CbGeAlD
Dasatinib—KIT—digestive system—rheumatoid arthritis	0.000176	0.00299	CbGeAlD
Dasatinib—PDGFRB—lymphoid tissue—rheumatoid arthritis	0.000174	0.00296	CbGeAlD
Dasatinib—PDGFRB—digestive system—rheumatoid arthritis	0.000172	0.00292	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Prednisone—rheumatoid arthritis	0.000171	0.0789	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Prednisolone—rheumatoid arthritis	0.000167	0.077	CbGdCrCtD
Dasatinib—PDGFRB—tendon—rheumatoid arthritis	0.000164	0.00278	CbGeAlD
Dasatinib—ABL1—lymphoid tissue—rheumatoid arthritis	0.000155	0.00264	CbGeAlD
Dasatinib—ABL1—digestive system—rheumatoid arthritis	0.000153	0.00261	CbGeAlD
Dasatinib—ABCG2—parotid gland—rheumatoid arthritis	0.000152	0.00259	CbGeAlD
Dasatinib—ABL1—tendon—rheumatoid arthritis	0.000146	0.00248	CbGeAlD
Dasatinib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000146	0.00248	CbGeAlD
Dasatinib—CYP1A1—parotid gland—rheumatoid arthritis	0.000144	0.00245	CbGeAlD
Dasatinib—CYP1B1—lymphoid tissue—rheumatoid arthritis	0.000131	0.00223	CbGeAlD
Dasatinib—CYP1B1—digestive system—rheumatoid arthritis	0.00013	0.00221	CbGeAlD
Dasatinib—CYP1B1—tendon—rheumatoid arthritis	0.000124	0.0021	CbGeAlD
Dasatinib—PKMYT1—Danazol—Hydrocortisone—rheumatoid arthritis	0.000112	0.052	CbGdCrCtD
Dasatinib—PKMYT1—Danazol—Prednisone—rheumatoid arthritis	9.68e-05	0.0447	CbGdCrCtD
Dasatinib—CYP1A2—digestive system—rheumatoid arthritis	9.31e-05	0.00158	CbGeAlD
Dasatinib—CYP1A1—digestive system—rheumatoid arthritis	9.18e-05	0.00156	CbGeAlD
Dasatinib—CYP3A5—digestive system—rheumatoid arthritis	8.98e-05	0.00153	CbGeAlD
Dasatinib—TESK1—Betamethasone—Hydrocortisone—rheumatoid arthritis	8.05e-05	0.0372	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Hydrocortisone—rheumatoid arthritis	8.05e-05	0.0372	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—rheumatoid arthritis	7.6e-05	0.0351	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—rheumatoid arthritis	7.6e-05	0.0351	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—rheumatoid arthritis	7.48e-05	0.0346	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—rheumatoid arthritis	7.48e-05	0.0346	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—rheumatoid arthritis	7.31e-05	0.0338	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Triamcinolone—rheumatoid arthritis	7.31e-05	0.0338	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisone—rheumatoid arthritis	6.94e-05	0.032	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—rheumatoid arthritis	6.94e-05	0.032	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—rheumatoid arthritis	6.77e-05	0.0313	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisolone—rheumatoid arthritis	6.77e-05	0.0313	CbGdCrCtD
Dasatinib—CYP3A4—digestive system—rheumatoid arthritis	6.74e-05	0.00114	CbGeAlD
Dasatinib—ABCB1—lymphoid tissue—rheumatoid arthritis	4.83e-05	0.00082	CbGeAlD
Dasatinib—ABCB1—digestive system—rheumatoid arthritis	4.77e-05	0.00081	CbGeAlD
Dasatinib—Myalgia—Betamethasone—rheumatoid arthritis	4.25e-05	0.000397	CcSEcCtD
Dasatinib—Abdominal pain—Cyclosporine—rheumatoid arthritis	4.24e-05	0.000396	CcSEcCtD
Dasatinib—Body temperature increased—Cyclosporine—rheumatoid arthritis	4.24e-05	0.000396	CcSEcCtD
Dasatinib—Anxiety—Dexamethasone—rheumatoid arthritis	4.24e-05	0.000395	CcSEcCtD
Dasatinib—Anxiety—Betamethasone—rheumatoid arthritis	4.24e-05	0.000395	CcSEcCtD
Dasatinib—Discomfort—Betamethasone—rheumatoid arthritis	4.2e-05	0.000392	CcSEcCtD
Dasatinib—Discomfort—Dexamethasone—rheumatoid arthritis	4.2e-05	0.000392	CcSEcCtD
Dasatinib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	4.2e-05	0.000392	CcSEcCtD
Dasatinib—Haemoglobin—Methotrexate—rheumatoid arthritis	4.2e-05	0.000392	CcSEcCtD
Dasatinib—Hypotension—Methylprednisolone—rheumatoid arthritis	4.19e-05	0.000391	CcSEcCtD
Dasatinib—Pain—Prednisolone—rheumatoid arthritis	4.18e-05	0.00039	CcSEcCtD
Dasatinib—Haemorrhage—Methotrexate—rheumatoid arthritis	4.18e-05	0.00039	CcSEcCtD
Dasatinib—Hepatitis—Methotrexate—rheumatoid arthritis	4.18e-05	0.00039	CcSEcCtD
Dasatinib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	4.15e-05	0.000387	CcSEcCtD
Dasatinib—Nausea—Leflunomide—rheumatoid arthritis	4.13e-05	0.000386	CcSEcCtD
Dasatinib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	4.12e-05	0.000385	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	4.12e-05	0.000384	CcSEcCtD
Dasatinib—Fatigue—Hydrocortisone—rheumatoid arthritis	4.11e-05	0.000384	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—rheumatoid arthritis	4.1e-05	0.000383	CcSEcCtD
Dasatinib—Urethral disorder—Methotrexate—rheumatoid arthritis	4.09e-05	0.000382	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	4.09e-05	0.000382	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	4.08e-05	0.000381	CcSEcCtD
Dasatinib—Pain—Hydrocortisone—rheumatoid arthritis	4.08e-05	0.000381	CcSEcCtD
Dasatinib—Oedema—Betamethasone—rheumatoid arthritis	4.08e-05	0.00038	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—rheumatoid arthritis	4.08e-05	0.00038	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—rheumatoid arthritis	4.06e-05	0.000379	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—rheumatoid arthritis	4.05e-05	0.000378	CcSEcCtD
Dasatinib—Infection—Dexamethasone—rheumatoid arthritis	4.05e-05	0.000378	CcSEcCtD
Dasatinib—Infection—Betamethasone—rheumatoid arthritis	4.05e-05	0.000378	CcSEcCtD
Dasatinib—Ill-defined disorder—Prednisone—rheumatoid arthritis	4.04e-05	0.000377	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—rheumatoid arthritis	4.03e-05	0.000376	CcSEcCtD
Dasatinib—Visual impairment—Methotrexate—rheumatoid arthritis	4.02e-05	0.000376	CcSEcCtD
Dasatinib—Anaemia—Prednisone—rheumatoid arthritis	4.02e-05	0.000375	CcSEcCtD
Dasatinib—Shock—Dexamethasone—rheumatoid arthritis	4.01e-05	0.000374	CcSEcCtD
Dasatinib—Shock—Betamethasone—rheumatoid arthritis	4.01e-05	0.000374	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—rheumatoid arthritis	4e-05	0.000374	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	4e-05	0.000373	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	4e-05	0.000373	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.99e-05	0.000372	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.99e-05	0.000372	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—rheumatoid arthritis	3.98e-05	0.000371	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—rheumatoid arthritis	3.98e-05	0.000371	CcSEcCtD
Dasatinib—Hypersensitivity—Cyclosporine—rheumatoid arthritis	3.95e-05	0.000369	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—rheumatoid arthritis	3.95e-05	0.000369	CcSEcCtD
Dasatinib—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.95e-05	0.000368	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	3.95e-05	0.000368	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	3.94e-05	0.000368	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—rheumatoid arthritis	3.94e-05	0.000368	CcSEcCtD
Dasatinib—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.93e-05	0.000367	CcSEcCtD
Dasatinib—Malaise—Prednisone—rheumatoid arthritis	3.92e-05	0.000366	CcSEcCtD
Dasatinib—Vertigo—Prednisone—rheumatoid arthritis	3.91e-05	0.000365	CcSEcCtD
Dasatinib—Eye disorder—Methotrexate—rheumatoid arthritis	3.9e-05	0.000364	CcSEcCtD
Dasatinib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.9e-05	0.000364	CcSEcCtD
Dasatinib—Syncope—Prednisone—rheumatoid arthritis	3.9e-05	0.000364	CcSEcCtD
Dasatinib—Tinnitus—Methotrexate—rheumatoid arthritis	3.89e-05	0.000363	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—rheumatoid arthritis	3.89e-05	0.000363	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—rheumatoid arthritis	3.89e-05	0.000363	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—rheumatoid arthritis	3.88e-05	0.000362	CcSEcCtD
Dasatinib—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.88e-05	0.000362	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—rheumatoid arthritis	3.87e-05	0.000361	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—rheumatoid arthritis	3.86e-05	0.000361	CcSEcCtD
Dasatinib—Asthenia—Cyclosporine—rheumatoid arthritis	3.85e-05	0.000359	CcSEcCtD
Dasatinib—Pain—Triamcinolone—rheumatoid arthritis	3.84e-05	0.000359	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—rheumatoid arthritis	3.82e-05	0.000357	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—rheumatoid arthritis	3.81e-05	0.000355	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—rheumatoid arthritis	3.81e-05	0.000355	CcSEcCtD
Dasatinib—Pruritus—Cyclosporine—rheumatoid arthritis	3.8e-05	0.000354	CcSEcCtD
Dasatinib—Urticaria—Hydrocortisone—rheumatoid arthritis	3.79e-05	0.000354	CcSEcCtD
Dasatinib—Angiopathy—Methotrexate—rheumatoid arthritis	3.79e-05	0.000354	CcSEcCtD
Dasatinib—Immune system disorder—Methotrexate—rheumatoid arthritis	3.77e-05	0.000352	CcSEcCtD
Dasatinib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.77e-05	0.000352	CcSEcCtD
Dasatinib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.77e-05	0.000352	CcSEcCtD
Dasatinib—Convulsion—Prednisone—rheumatoid arthritis	3.77e-05	0.000352	CcSEcCtD
Dasatinib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.76e-05	0.000351	CcSEcCtD
Dasatinib—Hypertension—Prednisone—rheumatoid arthritis	3.75e-05	0.00035	CcSEcCtD
Dasatinib—Chills—Methotrexate—rheumatoid arthritis	3.75e-05	0.00035	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3.71e-05	0.000347	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3.71e-05	0.000347	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—rheumatoid arthritis	3.7e-05	0.000346	CcSEcCtD
Dasatinib—Myalgia—Prednisone—rheumatoid arthritis	3.7e-05	0.000346	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—rheumatoid arthritis	3.7e-05	0.000345	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	3.69e-05	0.000345	CcSEcCtD
Dasatinib—Anxiety—Prednisone—rheumatoid arthritis	3.69e-05	0.000344	CcSEcCtD
Dasatinib—Alopecia—Methotrexate—rheumatoid arthritis	3.69e-05	0.000344	CcSEcCtD
Dasatinib—Insomnia—Betamethasone—rheumatoid arthritis	3.69e-05	0.000344	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—rheumatoid arthritis	3.69e-05	0.000344	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3.68e-05	0.000343	CcSEcCtD
Dasatinib—Diarrhoea—Cyclosporine—rheumatoid arthritis	3.67e-05	0.000343	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	3.67e-05	0.000342	CcSEcCtD
Dasatinib—Discomfort—Prednisone—rheumatoid arthritis	3.66e-05	0.000341	CcSEcCtD
Dasatinib—Mental disorder—Methotrexate—rheumatoid arthritis	3.66e-05	0.000341	CcSEcCtD
Dasatinib—Malnutrition—Methotrexate—rheumatoid arthritis	3.63e-05	0.000339	CcSEcCtD
Dasatinib—Erythema—Methotrexate—rheumatoid arthritis	3.63e-05	0.000339	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—rheumatoid arthritis	3.6e-05	0.000336	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—rheumatoid arthritis	3.59e-05	0.000335	CcSEcCtD
Dasatinib—Dyspepsia—Betamethasone—rheumatoid arthritis	3.59e-05	0.000335	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—rheumatoid arthritis	3.57e-05	0.000333	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—rheumatoid arthritis	3.56e-05	0.000332	CcSEcCtD
Dasatinib—Dysgeusia—Methotrexate—rheumatoid arthritis	3.56e-05	0.000332	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—rheumatoid arthritis	3.55e-05	0.000331	CcSEcCtD
Dasatinib—Dizziness—Cyclosporine—rheumatoid arthritis	3.55e-05	0.000331	CcSEcCtD
Dasatinib—Oedema—Prednisone—rheumatoid arthritis	3.55e-05	0.000331	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	3.54e-05	0.000331	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—rheumatoid arthritis	3.54e-05	0.000331	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—rheumatoid arthritis	3.54e-05	0.000331	CcSEcCtD
Dasatinib—Infection—Prednisone—rheumatoid arthritis	3.53e-05	0.000329	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	3.52e-05	0.000328	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	3.52e-05	0.000328	CcSEcCtD
Dasatinib—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	3.51e-05	0.000328	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—rheumatoid arthritis	3.51e-05	0.000328	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—rheumatoid arthritis	3.51e-05	0.000328	CcSEcCtD
Dasatinib—Shock—Prednisone—rheumatoid arthritis	3.49e-05	0.000326	CcSEcCtD
Dasatinib—Pain—Dexamethasone—rheumatoid arthritis	3.49e-05	0.000325	CcSEcCtD
Dasatinib—Pain—Betamethasone—rheumatoid arthritis	3.49e-05	0.000325	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—rheumatoid arthritis	3.48e-05	0.000325	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—rheumatoid arthritis	3.46e-05	0.000323	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—rheumatoid arthritis	3.45e-05	0.000322	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—rheumatoid arthritis	3.43e-05	0.00032	CcSEcCtD
Dasatinib—Vision blurred—Methotrexate—rheumatoid arthritis	3.43e-05	0.00032	CcSEcCtD
Dasatinib—Asthenia—Hydrocortisone—rheumatoid arthritis	3.42e-05	0.000319	CcSEcCtD
Dasatinib—Vomiting—Cyclosporine—rheumatoid arthritis	3.41e-05	0.000319	CcSEcCtD
Dasatinib—Rash—Cyclosporine—rheumatoid arthritis	3.38e-05	0.000316	CcSEcCtD
Dasatinib—Anorexia—Prednisone—rheumatoid arthritis	3.38e-05	0.000316	CcSEcCtD
Dasatinib—Dermatitis—Cyclosporine—rheumatoid arthritis	3.38e-05	0.000316	CcSEcCtD
Dasatinib—Pruritus—Hydrocortisone—rheumatoid arthritis	3.38e-05	0.000315	CcSEcCtD
Dasatinib—Ill-defined disorder—Methotrexate—rheumatoid arthritis	3.37e-05	0.000315	CcSEcCtD
Dasatinib—Headache—Cyclosporine—rheumatoid arthritis	3.36e-05	0.000314	CcSEcCtD
Dasatinib—Anaemia—Methotrexate—rheumatoid arthritis	3.36e-05	0.000314	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—rheumatoid arthritis	3.36e-05	0.000313	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—rheumatoid arthritis	3.36e-05	0.000313	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	3.33e-05	0.000311	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	3.33e-05	0.000311	CcSEcCtD
Dasatinib—Hypersensitivity—Triamcinolone—rheumatoid arthritis	3.31e-05	0.000309	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	3.3e-05	0.000308	CcSEcCtD
Dasatinib—Malaise—Methotrexate—rheumatoid arthritis	3.28e-05	0.000306	CcSEcCtD
Dasatinib—Vertigo—Methotrexate—rheumatoid arthritis	3.27e-05	0.000305	CcSEcCtD
Dasatinib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	3.26e-05	0.000305	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—rheumatoid arthritis	3.24e-05	0.000302	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—rheumatoid arthritis	3.24e-05	0.000302	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	3.23e-05	0.000302	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—rheumatoid arthritis	3.23e-05	0.000301	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—rheumatoid arthritis	3.22e-05	0.000301	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—rheumatoid arthritis	3.22e-05	0.000301	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—rheumatoid arthritis	3.22e-05	0.000301	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—rheumatoid arthritis	3.22e-05	0.000301	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—rheumatoid arthritis	3.22e-05	0.000301	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—rheumatoid arthritis	3.22e-05	0.0003	CcSEcCtD
Dasatinib—Insomnia—Prednisone—rheumatoid arthritis	3.21e-05	0.0003	CcSEcCtD
Dasatinib—Nausea—Cyclosporine—rheumatoid arthritis	3.19e-05	0.000298	CcSEcCtD
Dasatinib—Pruritus—Triamcinolone—rheumatoid arthritis	3.18e-05	0.000297	CcSEcCtD
Dasatinib—Cough—Methotrexate—rheumatoid arthritis	3.17e-05	0.000296	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—rheumatoid arthritis	3.17e-05	0.000296	CcSEcCtD
Dasatinib—Dizziness—Hydrocortisone—rheumatoid arthritis	3.15e-05	0.000294	CcSEcCtD
Dasatinib—Convulsion—Methotrexate—rheumatoid arthritis	3.15e-05	0.000294	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—rheumatoid arthritis	3.12e-05	0.000292	CcSEcCtD
Dasatinib—Chest pain—Methotrexate—rheumatoid arthritis	3.09e-05	0.000289	CcSEcCtD
Dasatinib—Arthralgia—Methotrexate—rheumatoid arthritis	3.09e-05	0.000289	CcSEcCtD
Dasatinib—Myalgia—Methotrexate—rheumatoid arthritis	3.09e-05	0.000289	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—rheumatoid arthritis	3.09e-05	0.000288	CcSEcCtD
Dasatinib—Rash—Prednisolone—rheumatoid arthritis	3.08e-05	0.000287	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—rheumatoid arthritis	3.08e-05	0.000287	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.07e-05	0.000287	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.07e-05	0.000286	CcSEcCtD
Dasatinib—Fatigue—Prednisone—rheumatoid arthritis	3.06e-05	0.000286	CcSEcCtD
Dasatinib—Headache—Prednisolone—rheumatoid arthritis	3.06e-05	0.000286	CcSEcCtD
Dasatinib—Discomfort—Methotrexate—rheumatoid arthritis	3.06e-05	0.000285	CcSEcCtD
Dasatinib—Constipation—Prednisone—rheumatoid arthritis	3.04e-05	0.000283	CcSEcCtD
Dasatinib—Vomiting—Hydrocortisone—rheumatoid arthritis	3.03e-05	0.000283	CcSEcCtD
Dasatinib—Rash—Hydrocortisone—rheumatoid arthritis	3.01e-05	0.000281	CcSEcCtD
Dasatinib—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.01e-05	0.00028	CcSEcCtD
Dasatinib—Confusional state—Methotrexate—rheumatoid arthritis	2.99e-05	0.000279	CcSEcCtD
Dasatinib—Headache—Hydrocortisone—rheumatoid arthritis	2.99e-05	0.000279	CcSEcCtD
Dasatinib—Dizziness—Triamcinolone—rheumatoid arthritis	2.97e-05	0.000277	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—rheumatoid arthritis	2.96e-05	0.000277	CcSEcCtD
Dasatinib—Infection—Methotrexate—rheumatoid arthritis	2.95e-05	0.000275	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—rheumatoid arthritis	2.93e-05	0.000273	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000273	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—rheumatoid arthritis	2.92e-05	0.000273	CcSEcCtD
Dasatinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.91e-05	0.000272	CcSEcCtD
Dasatinib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.9e-05	0.000271	CcSEcCtD
Dasatinib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.9e-05	0.000271	CcSEcCtD
Dasatinib—Nausea—Prednisolone—rheumatoid arthritis	2.9e-05	0.000271	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—rheumatoid arthritis	2.88e-05	0.000269	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—rheumatoid arthritis	2.88e-05	0.000269	CcSEcCtD
Dasatinib—Skin disorder—Methotrexate—rheumatoid arthritis	2.88e-05	0.000269	CcSEcCtD
Dasatinib—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.87e-05	0.000268	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—rheumatoid arthritis	2.86e-05	0.000267	CcSEcCtD
Dasatinib—Vomiting—Methylprednisolone—rheumatoid arthritis	2.85e-05	0.000266	CcSEcCtD
Dasatinib—Nausea—Hydrocortisone—rheumatoid arthritis	2.83e-05	0.000264	CcSEcCtD
Dasatinib—Rash—Triamcinolone—rheumatoid arthritis	2.83e-05	0.000264	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—rheumatoid arthritis	2.83e-05	0.000264	CcSEcCtD
Dasatinib—Anorexia—Methotrexate—rheumatoid arthritis	2.83e-05	0.000264	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—rheumatoid arthritis	2.83e-05	0.000264	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.82e-05	0.000264	CcSEcCtD
Dasatinib—Urticaria—Prednisone—rheumatoid arthritis	2.82e-05	0.000263	CcSEcCtD
Dasatinib—Headache—Triamcinolone—rheumatoid arthritis	2.81e-05	0.000263	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—rheumatoid arthritis	2.81e-05	0.000262	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—rheumatoid arthritis	2.81e-05	0.000262	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—rheumatoid arthritis	2.81e-05	0.000262	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.79e-05	0.00026	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—rheumatoid arthritis	2.79e-05	0.00026	CcSEcCtD
Dasatinib—Hypotension—Methotrexate—rheumatoid arthritis	2.77e-05	0.000259	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.7e-05	0.000252	CcSEcCtD
Dasatinib—Dizziness—Betamethasone—rheumatoid arthritis	2.7e-05	0.000252	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—rheumatoid arthritis	2.7e-05	0.000252	CcSEcCtD
Dasatinib—Insomnia—Methotrexate—rheumatoid arthritis	2.68e-05	0.00025	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—rheumatoid arthritis	2.67e-05	0.000249	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—rheumatoid arthritis	2.66e-05	0.000248	CcSEcCtD
Dasatinib—Dyspnoea—Methotrexate—rheumatoid arthritis	2.64e-05	0.000247	CcSEcCtD
Dasatinib—Somnolence—Methotrexate—rheumatoid arthritis	2.64e-05	0.000246	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—rheumatoid arthritis	2.62e-05	0.000244	CcSEcCtD
Dasatinib—Dyspepsia—Methotrexate—rheumatoid arthritis	2.61e-05	0.000244	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—rheumatoid arthritis	2.59e-05	0.000242	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—rheumatoid arthritis	2.59e-05	0.000242	CcSEcCtD
Dasatinib—Decreased appetite—Methotrexate—rheumatoid arthritis	2.58e-05	0.000241	CcSEcCtD
Dasatinib—Rash—Betamethasone—rheumatoid arthritis	2.57e-05	0.00024	CcSEcCtD
Dasatinib—Rash—Dexamethasone—rheumatoid arthritis	2.57e-05	0.00024	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—rheumatoid arthritis	2.57e-05	0.00024	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—rheumatoid arthritis	2.57e-05	0.00024	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.56e-05	0.000239	CcSEcCtD
Dasatinib—Fatigue—Methotrexate—rheumatoid arthritis	2.56e-05	0.000239	CcSEcCtD
Dasatinib—Headache—Betamethasone—rheumatoid arthritis	2.55e-05	0.000238	CcSEcCtD
Dasatinib—Headache—Dexamethasone—rheumatoid arthritis	2.55e-05	0.000238	CcSEcCtD
Dasatinib—Asthenia—Prednisone—rheumatoid arthritis	2.55e-05	0.000238	CcSEcCtD
Dasatinib—Pain—Methotrexate—rheumatoid arthritis	2.54e-05	0.000237	CcSEcCtD
Dasatinib—Pruritus—Prednisone—rheumatoid arthritis	2.51e-05	0.000234	CcSEcCtD
Dasatinib—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.44e-05	0.000228	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—rheumatoid arthritis	2.43e-05	0.000227	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.43e-05	0.000226	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—rheumatoid arthritis	2.42e-05	0.000226	CcSEcCtD
Dasatinib—Nausea—Betamethasone—rheumatoid arthritis	2.42e-05	0.000226	CcSEcCtD
Dasatinib—Urticaria—Methotrexate—rheumatoid arthritis	2.36e-05	0.00022	CcSEcCtD
Dasatinib—Dizziness—Prednisone—rheumatoid arthritis	2.35e-05	0.000219	CcSEcCtD
Dasatinib—Body temperature increased—Methotrexate—rheumatoid arthritis	2.35e-05	0.000219	CcSEcCtD
Dasatinib—Abdominal pain—Methotrexate—rheumatoid arthritis	2.35e-05	0.000219	CcSEcCtD
Dasatinib—Vomiting—Prednisone—rheumatoid arthritis	2.26e-05	0.000211	CcSEcCtD
Dasatinib—Rash—Prednisone—rheumatoid arthritis	2.24e-05	0.000209	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—rheumatoid arthritis	2.24e-05	0.000209	CcSEcCtD
Dasatinib—Headache—Prednisone—rheumatoid arthritis	2.22e-05	0.000208	CcSEcCtD
Dasatinib—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.19e-05	0.000204	CcSEcCtD
Dasatinib—Asthenia—Methotrexate—rheumatoid arthritis	2.13e-05	0.000199	CcSEcCtD
Dasatinib—Nausea—Prednisone—rheumatoid arthritis	2.11e-05	0.000197	CcSEcCtD
Dasatinib—Pruritus—Methotrexate—rheumatoid arthritis	2.1e-05	0.000196	CcSEcCtD
Dasatinib—Diarrhoea—Methotrexate—rheumatoid arthritis	2.03e-05	0.000189	CcSEcCtD
Dasatinib—Dizziness—Methotrexate—rheumatoid arthritis	1.96e-05	0.000183	CcSEcCtD
Dasatinib—Vomiting—Methotrexate—rheumatoid arthritis	1.89e-05	0.000176	CcSEcCtD
Dasatinib—Rash—Methotrexate—rheumatoid arthritis	1.87e-05	0.000175	CcSEcCtD
Dasatinib—Dermatitis—Methotrexate—rheumatoid arthritis	1.87e-05	0.000174	CcSEcCtD
Dasatinib—Headache—Methotrexate—rheumatoid arthritis	1.86e-05	0.000173	CcSEcCtD
Dasatinib—Nausea—Methotrexate—rheumatoid arthritis	1.76e-05	0.000164	CcSEcCtD
Dasatinib—SRC—Signaling Pathways—CSF2—rheumatoid arthritis	7.1e-07	4.48e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NFKB1—rheumatoid arthritis	7.1e-07	4.48e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6R—rheumatoid arthritis	7.07e-07	4.46e-06	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—IL6—rheumatoid arthritis	7.05e-07	4.45e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TYK2—rheumatoid arthritis	7.04e-07	4.45e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NFKB1—rheumatoid arthritis	7.01e-07	4.42e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—POMC—rheumatoid arthritis	6.99e-07	4.41e-06	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	6.99e-07	4.41e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TGFB1—rheumatoid arthritis	6.99e-07	4.41e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCL2—rheumatoid arthritis	6.99e-07	4.41e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—MAPK8—rheumatoid arthritis	6.98e-07	4.4e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CD80—rheumatoid arthritis	6.98e-07	4.4e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—TYK2—rheumatoid arthritis	6.97e-07	4.4e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6R—rheumatoid arthritis	6.97e-07	4.4e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—VEGFA—rheumatoid arthritis	6.96e-07	4.4e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL2—rheumatoid arthritis	6.93e-07	4.38e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NOS3—rheumatoid arthritis	6.91e-07	4.36e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—TGFB1—rheumatoid arthritis	6.9e-07	4.35e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—MAPK8—rheumatoid arthritis	6.89e-07	4.35e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CD80—rheumatoid arthritis	6.89e-07	4.35e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—POMC—rheumatoid arthritis	6.88e-07	4.35e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCL2—rheumatoid arthritis	6.84e-07	4.32e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6R—rheumatoid arthritis	6.82e-07	4.31e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	6.82e-07	4.3e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	6.82e-07	4.3e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCL2—rheumatoid arthritis	6.74e-07	4.25e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CAT—rheumatoid arthritis	6.73e-07	4.25e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6R—rheumatoid arthritis	6.72e-07	4.24e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—VEGFA—rheumatoid arthritis	6.71e-07	4.24e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SPP1—rheumatoid arthritis	6.67e-07	4.21e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—LEP—rheumatoid arthritis	6.67e-07	4.21e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—ALB—rheumatoid arthritis	6.65e-07	4.2e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—POMC—rheumatoid arthritis	6.64e-07	4.19e-06	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—IL6—rheumatoid arthritis	6.63e-07	4.18e-06	CbGpPWpGaD
Dasatinib—ERBB3—Disease—IL6—rheumatoid arthritis	6.63e-07	4.18e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—POMC—rheumatoid arthritis	6.63e-07	4.18e-06	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—IL6—rheumatoid arthritis	6.61e-07	4.17e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL1B—rheumatoid arthritis	6.58e-07	4.15e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—CD4—rheumatoid arthritis	6.58e-07	4.15e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MMP9—rheumatoid arthritis	6.56e-07	4.14e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL2—rheumatoid arthritis	6.55e-07	4.14e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—POMC—rheumatoid arthritis	6.54e-07	4.13e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IFNG—rheumatoid arthritis	6.53e-07	4.12e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—TGFB1—rheumatoid arthritis	6.53e-07	4.12e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—PTGS2—rheumatoid arthritis	6.53e-07	4.12e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR5—rheumatoid arthritis	6.49e-07	4.1e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NFKB1—rheumatoid arthritis	6.49e-07	4.1e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCL2—rheumatoid arthritis	6.49e-07	4.09e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CXCL8—rheumatoid arthritis	6.48e-07	4.09e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6R—rheumatoid arthritis	6.47e-07	4.08e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TYK2—rheumatoid arthritis	6.44e-07	4.06e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.44e-07	4.06e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCL2—rheumatoid arthritis	6.4e-07	4.04e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2RA—rheumatoid arthritis	6.4e-07	4.04e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TGFB1—rheumatoid arthritis	6.39e-07	4.03e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6R—rheumatoid arthritis	6.38e-07	4.03e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—MAPK8—rheumatoid arthritis	6.38e-07	4.03e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—rheumatoid arthritis	6.37e-07	4.02e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TYK2—rheumatoid arthritis	6.35e-07	4e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—C3—rheumatoid arthritis	6.34e-07	4e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—rheumatoid arthritis	6.32e-07	3.99e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—CD4—rheumatoid arthritis	6.31e-07	3.98e-06	CbGpPWpGaD
Dasatinib—YES1—Immune System—IL6—rheumatoid arthritis	6.3e-07	3.98e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—FN1—rheumatoid arthritis	6.29e-07	3.97e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6ST—rheumatoid arthritis	6.27e-07	3.96e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—rheumatoid arthritis	6.23e-07	3.93e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TYK2—rheumatoid arthritis	6.21e-07	3.92e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL2—rheumatoid arthritis	6.19e-07	3.91e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TGFB1—rheumatoid arthritis	6.16e-07	3.89e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—NFKB1—rheumatoid arthritis	6.14e-07	3.87e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	6.14e-07	3.87e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CXCL8—rheumatoid arthritis	6.13e-07	3.87e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TYK2—rheumatoid arthritis	6.12e-07	3.86e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—rheumatoid arthritis	6.1e-07	3.85e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—ALB—rheumatoid arthritis	6.05e-07	3.82e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—MAPK8—rheumatoid arthritis	6.03e-07	3.81e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CD80—rheumatoid arthritis	6.03e-07	3.81e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—rheumatoid arthritis	6e-07	3.79e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	5.97e-07	3.76e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	5.95e-07	3.75e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—LEP—rheumatoid arthritis	5.91e-07	3.73e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—VEGFA—rheumatoid arthritis	5.89e-07	3.72e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TYK2—rheumatoid arthritis	5.89e-07	3.72e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—TGFB1—rheumatoid arthritis	5.88e-07	3.71e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.87e-07	3.7e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL2—rheumatoid arthritis	5.86e-07	3.7e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MMP9—rheumatoid arthritis	5.86e-07	3.7e-06	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—IL6—rheumatoid arthritis	5.86e-07	3.7e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL1B—rheumatoid arthritis	5.82e-07	3.68e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—CD4—rheumatoid arthritis	5.82e-07	3.67e-06	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—PTGS2—rheumatoid arthritis	5.82e-07	3.67e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TYK2—rheumatoid arthritis	5.81e-07	3.67e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL2—rheumatoid arthritis	5.8e-07	3.66e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NFKB1—rheumatoid arthritis	5.8e-07	3.66e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	5.79e-07	3.65e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—rheumatoid arthritis	5.78e-07	3.65e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—PTGS2—rheumatoid arthritis	5.78e-07	3.65e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—TP53—rheumatoid arthritis	5.75e-07	3.63e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—POMC—rheumatoid arthritis	5.73e-07	3.62e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—rheumatoid arthritis	5.71e-07	3.6e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—MAPK8—rheumatoid arthritis	5.7e-07	3.6e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—TGFB1—rheumatoid arthritis	5.67e-07	3.58e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	5.65e-07	3.56e-06	CbGpPWpGaD
Dasatinib—KIT—Immune System—IL6—rheumatoid arthritis	5.63e-07	3.55e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MTHFR—rheumatoid arthritis	5.62e-07	3.55e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCL2—rheumatoid arthritis	5.61e-07	3.54e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6R—rheumatoid arthritis	5.59e-07	3.53e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—FN1—rheumatoid arthritis	5.57e-07	3.52e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6ST—rheumatoid arthritis	5.55e-07	3.5e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MMP9—rheumatoid arthritis	5.55e-07	3.5e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL8—rheumatoid arthritis	5.53e-07	3.49e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NFKB1—rheumatoid arthritis	5.49e-07	3.46e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—NFKB1—rheumatoid arthritis	5.43e-07	3.43e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL8—rheumatoid arthritis	5.41e-07	3.41e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TGFB1—rheumatoid arthritis	5.41e-07	3.41e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—MAPK8—rheumatoid arthritis	5.39e-07	3.4e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—TGFB1—rheumatoid arthritis	5.39e-07	3.4e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAT—rheumatoid arthritis	5.38e-07	3.39e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—MAPK8—rheumatoid arthritis	5.34e-07	3.37e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CD80—rheumatoid arthritis	5.34e-07	3.37e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—IL6—rheumatoid arthritis	5.33e-07	3.36e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL8—rheumatoid arthritis	5.33e-07	3.36e-06	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	5.3e-07	3.34e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL2—rheumatoid arthritis	5.28e-07	3.33e-06	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—IL6—rheumatoid arthritis	5.27e-07	3.32e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—VEGFA—rheumatoid arthritis	5.26e-07	3.32e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—TP53—rheumatoid arthritis	5.26e-07	3.32e-06	CbGpPWpGaD
Dasatinib—KIT—Disease—IL6—rheumatoid arthritis	5.2e-07	3.28e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL2—rheumatoid arthritis	5.17e-07	3.26e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.13e-07	3.24e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—rheumatoid arthritis	5.13e-07	3.24e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TYK2—rheumatoid arthritis	5.09e-07	3.21e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL2—rheumatoid arthritis	5.09e-07	3.21e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—POMC—rheumatoid arthritis	5.07e-07	3.2e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—TP53—rheumatoid arthritis	5.07e-07	3.2e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—rheumatoid arthritis	5.06e-07	3.19e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—rheumatoid arthritis	5e-07	3.15e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MMP9—rheumatoid arthritis	5e-07	3.15e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—VEGFA—rheumatoid arthritis	4.98e-07	3.14e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCL2—rheumatoid arthritis	4.96e-07	3.13e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6R—rheumatoid arthritis	4.95e-07	3.12e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NFKB1—rheumatoid arthritis	4.94e-07	3.12e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—IL6—rheumatoid arthritis	4.92e-07	3.1e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL2—rheumatoid arthritis	4.9e-07	3.09e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MMP9—rheumatoid arthritis	4.89e-07	3.09e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—MAPK8—rheumatoid arthritis	4.86e-07	3.07e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NFKB1—rheumatoid arthritis	4.84e-07	3.06e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL2—rheumatoid arthritis	4.84e-07	3.05e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TGFB1—rheumatoid arthritis	4.83e-07	3.05e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MMP9—rheumatoid arthritis	4.82e-07	3.04e-06	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—IL6—rheumatoid arthritis	4.82e-07	3.04e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—IL6—rheumatoid arthritis	4.81e-07	3.04e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—IL6—rheumatoid arthritis	4.8e-07	3.03e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NFKB1—rheumatoid arthritis	4.77e-07	3.01e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—MAPK8—rheumatoid arthritis	4.76e-07	3e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—POMC—rheumatoid arthritis	4.76e-07	3e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—TGFB1—rheumatoid arthritis	4.72e-07	2.98e-06	CbGpPWpGaD
Dasatinib—LYN—Immune System—IL6—rheumatoid arthritis	4.7e-07	2.97e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—MAPK8—rheumatoid arthritis	4.68e-07	2.96e-06	CbGpPWpGaD
Dasatinib—ABL1—Immune System—IL6—rheumatoid arthritis	4.68e-07	2.95e-06	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—IL6—rheumatoid arthritis	4.64e-07	2.93e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MMP9—rheumatoid arthritis	4.64e-07	2.93e-06	CbGpPWpGaD
Dasatinib—FYN—Immune System—IL6—rheumatoid arthritis	4.63e-07	2.92e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	4.6e-07	2.91e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NFKB1—rheumatoid arthritis	4.59e-07	2.9e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MMP9—rheumatoid arthritis	4.58e-07	2.89e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TGFB1—rheumatoid arthritis	4.57e-07	2.89e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NFKB1—rheumatoid arthritis	4.53e-07	2.86e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—MAPK8—rheumatoid arthritis	4.51e-07	2.85e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TYK2—rheumatoid arthritis	4.51e-07	2.85e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—POMC—rheumatoid arthritis	4.5e-07	2.84e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	4.49e-07	2.83e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—VEGFA—rheumatoid arthritis	4.49e-07	2.83e-06	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—IL6—rheumatoid arthritis	4.46e-07	2.81e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—MAPK8—rheumatoid arthritis	4.45e-07	2.81e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—TP53—rheumatoid arthritis	4.45e-07	2.81e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—rheumatoid arthritis	4.43e-07	2.8e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—IL6—rheumatoid arthritis	4.43e-07	2.8e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—rheumatoid arthritis	4.43e-07	2.79e-06	CbGpPWpGaD
Dasatinib—JAK2—Immune System—IL6—rheumatoid arthritis	4.4e-07	2.78e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—VEGFA—rheumatoid arthritis	4.39e-07	2.77e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—ALB—rheumatoid arthritis	4.34e-07	2.74e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—VEGFA—rheumatoid arthritis	4.33e-07	2.73e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAT—rheumatoid arthritis	4.29e-07	2.71e-06	CbGpPWpGaD
Dasatinib—FYN—Disease—IL6—rheumatoid arthritis	4.27e-07	2.7e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL2—rheumatoid arthritis	4.24e-07	2.67e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—TGFB1—rheumatoid arthritis	4.18e-07	2.64e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—VEGFA—rheumatoid arthritis	4.17e-07	2.63e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	4.15e-07	2.62e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TGFB1—rheumatoid arthritis	4.12e-07	2.6e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—VEGFA—rheumatoid arthritis	4.11e-07	2.59e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—ALB—rheumatoid arthritis	4.1e-07	2.59e-06	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—IL6—rheumatoid arthritis	4.08e-07	2.57e-06	CbGpPWpGaD
Dasatinib—JAK2—Disease—IL6—rheumatoid arthritis	4.06e-07	2.56e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TGFB1—rheumatoid arthritis	4.03e-07	2.55e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MMP9—rheumatoid arthritis	4.01e-07	2.53e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—TP53—rheumatoid arthritis	3.98e-07	2.51e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TGFB1—rheumatoid arthritis	3.97e-07	2.51e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NFKB1—rheumatoid arthritis	3.97e-07	2.5e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—rheumatoid arthritis	3.93e-07	2.48e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—rheumatoid arthritis	3.92e-07	2.47e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—MAPK8—rheumatoid arthritis	3.9e-07	2.46e-06	CbGpPWpGaD
Dasatinib—LCK—Immune System—IL6—rheumatoid arthritis	3.85e-07	2.43e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TGFB1—rheumatoid arthritis	3.82e-07	2.41e-06	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	3.8e-07	2.4e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TGFB1—rheumatoid arthritis	3.77e-07	2.38e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—TP53—rheumatoid arthritis	3.76e-07	2.38e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL2—rheumatoid arthritis	3.75e-07	2.37e-06	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—IL6—rheumatoid arthritis	3.64e-07	2.3e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—VEGFA—rheumatoid arthritis	3.6e-07	2.27e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—POMC—rheumatoid arthritis	3.59e-07	2.27e-06	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—PTGS2—rheumatoid arthritis	3.59e-07	2.26e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	3.58e-07	2.26e-06	CbGpPWpGaD
Dasatinib—LCK—Disease—IL6—rheumatoid arthritis	3.56e-07	2.24e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MMP9—rheumatoid arthritis	3.55e-07	2.24e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NFKB1—rheumatoid arthritis	3.51e-07	2.22e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—MAPK8—rheumatoid arthritis	3.45e-07	2.18e-06	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—IL6—rheumatoid arthritis	3.45e-07	2.17e-06	CbGpPWpGaD
Dasatinib—SRC—Immune System—IL6—rheumatoid arthritis	3.41e-07	2.15e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—TP53—rheumatoid arthritis	3.39e-07	2.14e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—TP53—rheumatoid arthritis	3.32e-07	2.1e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	3.31e-07	2.09e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TGFB1—rheumatoid arthritis	3.31e-07	2.09e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.27e-07	2.07e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—TP53—rheumatoid arthritis	3.27e-07	2.06e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—VEGFA—rheumatoid arthritis	3.19e-07	2.01e-06	CbGpPWpGaD
Dasatinib—SRC—Disease—IL6—rheumatoid arthritis	3.15e-07	1.99e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—TP53—rheumatoid arthritis	3.15e-07	1.99e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	3.13e-07	1.98e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—TP53—rheumatoid arthritis	3.11e-07	1.96e-06	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—IL6—rheumatoid arthritis	3.1e-07	1.96e-06	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—IL6—rheumatoid arthritis	3.04e-07	1.92e-06	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—IL6—rheumatoid arthritis	2.99e-07	1.89e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TGFB1—rheumatoid arthritis	2.93e-07	1.85e-06	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—IL6—rheumatoid arthritis	2.88e-07	1.82e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—POMC—rheumatoid arthritis	2.87e-07	1.81e-06	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	2.86e-07	1.81e-06	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—IL6—rheumatoid arthritis	2.84e-07	1.79e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.77e-07	1.75e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—TP53—rheumatoid arthritis	2.72e-07	1.72e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—ALB—rheumatoid arthritis	2.61e-07	1.65e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	2.5e-07	1.58e-06	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—IL6—rheumatoid arthritis	2.49e-07	1.57e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—TP53—rheumatoid arthritis	2.41e-07	1.52e-06	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.29e-07	1.44e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.21e-07	1.4e-06	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—IL6—rheumatoid arthritis	2.21e-07	1.39e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.02e-07	1.27e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.93e-07	1.22e-06	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.76e-07	1.11e-06	CbGpPWpGaD
